Global EDTA Tubes Market Size By Type (Glass, Plastic), By Application (Venous Blood Collection, Capillary Blood Collection), By Region, And Segment Forecasts, 2023 to 2032

The Global EDTA Tubes Market was valued at USD 815 million in 2023 and is projected to surpass USD 1.3 billion by 2031, growing at a CAGR of 6.2% during the forecast period of 2023–2031. EDTA tubes, primarily used for blood sample collection and preservation in clinical laboratories, are critical in hematology and molecular diagnostics. The increasing global prevalence of chronic diseases, rising demand for reliable diagnostic testing, and expansion of healthcare infrastructure are the key factors driving market growth. Moreover, technological advancements in tube manufacturing and automation in diagnostic laboratories are further bolstering the demand.

Drivers

Rising Demand for Accurate Diagnostic Testing

The growing burden of chronic diseases such as diabetes, cancer, and cardiovascular disorders has led to an increased need for precise diagnostic solutions. EDTA tubes help preserve blood integrity, enabling reliable hematological and molecular analyses.

Advancements in Laboratory Automation

Integration of EDTA tubes with automated laboratory systems enhances workflow efficiency and sample integrity, which is accelerating their adoption in both developed and developing markets.

Expansion of Global Healthcare Infrastructure

Increased government and private investment in healthcare infrastructure, especially in emerging economies, is facilitating the installation of modern diagnostic facilities, supporting the growth of EDTA tube usage.

Restraints

Limited Shelf Life and Storage Constraints

EDTA tubes have specific storage and temperature requirements. Improper handling can compromise sample quality, posing a restraint for small-scale diagnostic centers lacking advanced storage systems.

Environmental Concerns and Disposal Issues

The widespread use of plastic-based EDTA tubes raises environmental concerns, particularly in regions with inadequate medical waste management systems, potentially impeding market growth.

Opportunity

Rising Point-of-Care Testing (POCT) Adoption

The growing trend towards decentralized diagnostic solutions and point-of-care testing presents a significant opportunity for EDTA tube manufacturers, especially for rapid diagnostics and mobile clinics.

Innovations in Tube Material and Coating Technologies

Research and development in biocompatible materials and vacuum technology are leading to the creation of EDTA tubes with enhanced durability, shelf life, and sample protection, opening up new market avenues.

Market by System Type Insights

By system type, the Plastic EDTA Tubes segment dominated the market in 2023, accounting for the largest share. These tubes are lightweight, cost-effective, and increasingly preferred for routine blood testing. However, Glass EDTA Tubes remain vital in specific high-sensitivity applications and are gaining attention in research laboratories.

Market by End-use Insights

In terms of end-use, the Hospitals & Clinics segment led the market in 2023 with over 50% revenue share. This dominance is attributed to the high volume of routine blood testing conducted for inpatients and outpatients. Diagnostic Laboratories follow closely, propelled by the growing trend of outsourcing clinical diagnostics for efficiency and cost savings.

Market by Regional Insights

North America held the largest market share in 2023, driven by its advanced healthcare infrastructure, high awareness regarding preventive diagnostics, and strong presence of leading market players. Asia-Pacific is projected to exhibit the fastest growth during the forecast period due to improving healthcare services, increasing diagnostic awareness, and a growing aging population in countries like China and India.

Competitive Scenario

Key players operating in the Global EDTA Tubes Market include Becton, Dickinson and Company, Greiner Bio-One International GmbH, Terumo Corporation, Cardinal Health, SARSTEDT AG & Co. KG, FL Medical, Biosigma S.p.A., Labtech Disposables, and Improve Medical. These companies are investing in product innovations, geographic expansion, and strategic collaborations to strengthen their market position.

Scope of Work – Global EDTA Tubes Market

Report Metric Details

Market Size (2023) USD 815 million

Projected Market Size (2031) USD 1.3 billion

CAGR (2023–2031) 6.2%

Market Segments By System Type, By End-Use, By Region

Growth Drivers Rise in chronic diseases, lab automation, global healthcare investments

Opportunities POCT expansion, biocompatible innovations

Key Market Developments

2023: Becton, Dickinson and Company introduced a new range of sustainable EDTA tubes using bioplastic, enhancing environmental sustainability without compromising sample quality.

2024: SARSTEDT AG & Co. KG expanded its manufacturing facilities in Asia-Pacific to cater to rising demand in emerging markets.

2025: Greiner Bio-One announced a strategic partnership with a diagnostics software firm to integrate EDTA tube data with laboratory information systems for enhanced traceability.

FAQs

What is the current market size of the Global EDTA Tubes Market?

The Global EDTA Tubes Market was valued at USD 815 million in 2023.

What is the major growth driver of the Global EDTA Tubes Market?

The rising prevalence of chronic diseases and the demand for accurate diagnostic testing are major growth drivers.

Which is the largest region during the forecast period in the Global EDTA Tubes Market?

North America is the largest region, owing to its robust healthcare infrastructure and early adoption of advanced diagnostics.

Which segment accounted for the largest market share in the Global EDTA Tubes Market?

The Hospitals & Clinics segment accounted for the largest market share in 2023.

Who are the key market players in the Global EDTA Tubes Market?

Key players include Becton, Dickinson and Company, Greiner Bio-One, Terumo Corporation, and Cardinal Health.